As of 2025-08-09, the EV/EBITDA ratio of Cell Biotech Co Ltd (049960.KQ) is 7.00. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 049960.KQ's latest enterprise value is 79,266.75 mil KRW. 049960.KQ's TTM EBITDA according to its financial statements is 11,322.40 mil KRW. Dividing these 2 quantities gives us the above 049960.KQ EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 22.6x - 42.6x | 41.7x |
| Forward P/E multiples | 8.7x - 23.2x | 10.4x |
| Fair Price | 11,306.62 - 67,974.49 | 39,846.57 |
| Upside | -14.0% - 417.3% | 203.2% |
| Date | EV/EBITDA |
| 2025-08-08 | 7.00 |
| 2025-08-07 | 7.01 |
| 2025-08-06 | 7.05 |
| 2025-08-05 | 7.12 |
| 2025-08-04 | 7.01 |
| 2025-08-01 | 7.03 |
| 2025-07-31 | 7.13 |
| 2025-07-30 | 7.18 |
| 2025-07-29 | 7.18 |
| 2025-07-28 | 7.36 |
| 2025-07-25 | 7.31 |
| 2025-07-24 | 7.36 |
| 2025-07-23 | 7.60 |
| 2025-07-22 | 7.71 |
| 2025-07-21 | 7.49 |
| 2025-07-18 | 7.48 |
| 2025-07-17 | 7.56 |
| 2025-07-16 | 7.31 |
| 2025-07-15 | 7.36 |
| 2025-07-14 | 7.36 |
| 2025-07-11 | 7.32 |
| 2025-07-10 | 7.35 |
| 2025-07-09 | 7.36 |
| 2025-07-08 | 7.01 |
| 2025-07-07 | 6.97 |
| 2025-07-04 | 6.88 |
| 2025-07-03 | 6.91 |
| 2025-07-02 | 6.90 |
| 2025-07-01 | 6.83 |
| 2025-06-30 | 6.66 |
| 2025-06-27 | 6.81 |
| 2025-06-26 | 6.80 |
| 2025-06-25 | 6.93 |
| 2025-06-24 | 6.86 |
| 2025-06-23 | 6.90 |
| 2025-06-20 | 7.07 |
| 2025-06-19 | 7.05 |
| 2025-06-18 | 7.01 |
| 2025-06-17 | 6.98 |
| 2025-06-16 | 7.03 |
| 2025-06-13 | 7.16 |
| 2025-06-12 | 7.30 |
| 2025-06-11 | 7.21 |
| 2025-06-10 | 7.08 |
| 2025-06-09 | 7.07 |
| 2025-06-05 | 6.94 |
| 2025-06-04 | 6.96 |
| 2025-06-02 | 6.85 |
| 2025-05-30 | 6.86 |
| 2025-05-29 | 6.86 |